Role of the stromal microenvironment in carcinogenesis of the prostate

International Journal of Cancer

Volumn 107, Issue 1, 2003, Pages 1-10

  Cunha, Gerald R ^a   Hayward, Simon W ^b   Wang, Y Z ^c   Ricke, William A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Androgen receptor; Estrogen receptor; Microenvironment; Prostate; Prostate cancer; Tumor

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; TESTOSTERONE;

ANIMAL CELL; ANIMAL TISSUE; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; DEVELOPMENT; EPITHELIUM CELL; FETUS; FIBROBLAST; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; MALE; MALIGNANT TRANSFORMATION; MESENCHYME; MICROENVIRONMENT; MOUSE; NONHUMAN; PARACRINE SIGNALING; PREPUBERTY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; RAT; SHORT SURVEY; SMOOTH MUSCLE; STROMA; UROGENITAL SINUS;

ANIMALS; HUMANS; MALE; PROSTATIC NEOPLASMS; RATS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; STROMAL CELLS;

EID: 0042415425     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11335     Document Type: Short Survey

References (120)

1. Ingber DE, Jamieson JD. Tumor formation and malignant invasion: role of basal lamina. In: Liotta L, Hart I, eds. Tumor invasion and metastasis. The Hague, Netherlands: Martinus Nijhoff, 1982. 335-57.
2. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, et al. The endocrinology and developmental biology of the prostate. Endocrine Rev 1987;8:338-62.
3. Cunha GR, Fujii H, Neubauer BL, Shannon JM, Sawyer LM, Reese BA. Epithelial-mesenchymal interactions in prostatic development: I. morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder. J Cell Biol 1983;96:1662-70.
4. Cunha GR, Sekkingstad M, Meloy BA. Heterospecific induction of prostatic development in tissue recombinants prepared with mouse, rat, rabbit, and human tissues. Differentiation 1983;24:174-80.
5. Cunha GR, Reese BA, Sekkingstad M. Induction of nuclear androgen-binding sites in epithelium of the embryonic urinary bladder by mesenchyme of the urogenital sinus of embryonic mice. Endocrinology 1980;107:1767-70.
6. Cunha GR. Androgenic effects upon prostatic epithelium are mediated via trophic influences from stroma. In: Kimball FA, Buhl AE, Carter DB, eds. New approaches to the study of benign prostatic hyperplasia. New York: Liss. 1984, 81-102.
7. Cunha GR, Young P. Inability of Tfm (testicular feminization) epithelial cells to express androgen-dependent seminal vesicle secretory proteins in chimeric tissue recombinants. Endocrinology 1991;128: 3293-8.
8. Cunha GR, Battle E, Young P, Brody J, Donjacour A, Hayashi N, et al. Role of epithelial-mesenchymal interactions in the differentiation and spatial organization of visceral smooth muscle. Epithelial Cell Biol 1992;1:76-83.
9. Hayward SW, Cunha GR, Dahiya R. Normal development and carcinogenesis of the prostate: a unifying hypothesis. Ann NY Acad Sci 1996;784:50-62.
10. Hayward SW, Haughney PC, Rosen MA, Greulich KM, Weier HU, Dahiya R, et al. Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation 1998;63:131-40.
11. Cooke PS, Young P, Cunha GR. Androgen receptor expression in developing male reproductive organs. Endocrinology 1991;128:2867-73.
12. Takeda H, Chang C. Immunohistochemical and in situ hybridization analysis of androgen receptor expression during the development of the mouse prostate gland. J Endocrinol 1991;129:83-9.
13. Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA. Normal and abnormal development of the male urogenital tract: role of androgens, mesenchymal-epithelial interactions and growth factors. J Androl 1992;13:465-75.
14. Donjacour AA, Cunha GR. Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice. Endocrinology 1993;131:2342-50.
15. Risbridger G, Wang H, Frydenberg M, Cunha GR. The metaplastic effects of estrogen on prostate epithelium: proliferation of cells with basal cell phenotype. Endocrinology 2001;142:2443-50.
16. Risbridger G, Wang H, Young P, Kurita T, Wong Y, Lubahn D, et al. Evidence that epithelial and mesenchymal estrogen receptor-a mediates effects of estrogen on prostatic epithelium. Dev Biol 2001;229: 432-42.
17. Cooke PS, Young P, Hess RA, Cunha GR. Estrogen receptor expression in developing epididymis, efferent ductules and other male reproductive organs. Endocrinology 1991;128:2874-9.
18. Prins GS, Birch L. Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology 1997;138:1801-9.
19. Prins GS, Marmer M, Woodham C, Chang W, Kuiper G, Gustafsson JA, et al. Estrogen receptor-beta messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology 1998;139:874-83.
20. Prins GS, Birch L, Couse JF, Choi I, Katzenellenbogen B, Korach KS. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alpha-ERKO and beta-ERKO mice. Cancer Res 2001;61:6089-97.
21. Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, et al. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 2001;98:6330-5.
22. Montie JE, Pienta KJ. Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer. Urology 1994;43:892-9.
23. Brendler CB, Berry SJ, Ewing LL, McCullough AR, Cochran RC, Strandberg JD, et al. Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate. J Clin Invest 1983;71:1114-23.
24. Hayes RB, de Jong FH, Raatgever J, Bogdanovicz J, Schroeder FH, van der Maas P, et al. Physical characteristics and factors related to sexual development and behaviour and the risk for prostatic cancer. Eur J Cancer Prev 1992;1:239-45.
25. Ross R, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 1986;76:45-8.
26. Ho SM, Yu M. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats. Cancer Res 1993; 53:528-32.
27. Leav I, Ho SM, Ofner P, Merk FB, Kwan PW, Damassa D. Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst 1988;80: 1045-53.
28. Noble RL. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 1977; 37:1929-33.
29. Yu M, Leav BA, Leav I, Merk FB, Wolfe HJ, Ho SM. Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats. Lab Invest 1993;68:33-44.
30. Wang YZ, Wong YC. Sex hormone-induced prostatic carcinogenesis in the noble rat: the role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer. Prostate 1998;35:165-77.
31. Wang YZ, Hayward SW, Cao M, Young P, Cardiff R, Cunha G. Role of estrogen signaling in prostatic hormonal carcinogenesis. J Urol 2001;165:1320.
32. Wang Y, Hayward SW, Donjacour AA, Young P, Jacks T, Sage J, et al. Hormonal carcinogenesis of the Rb-knockout mouse prostate. Cancer Res 2000;60:6008-17.
33. Cunha GR, Chung LWK. Stromal-epithelial interactions: I. induction of prostatic phenotype in urothelium of testicular feminized (Tfm/y) mice. J Steroid Biochem 1981;14:1317-21.
34. Shannon JM, Cunha GR. Characterization of androgen binding and deoxyribonucleic acid synthesis in prostate-like structures induced in testicular feminized (Tfm/Y) mice. Biol Reprod 1984;31:175-83.
35. Sugimura Y, Cunha GR, Bigsby RM. Androgenic induction of deoxyribonucleic acid synthesis in prostatic glands induced in the urothelium of testicular feminized (Tfm/y) mice. Prostate 1986;9: 217-25.
36. Cunha GR. Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 1994;74:1030-44.
37. Hayward SW, Rosen MA, Cunha GR. Stromal-epithelial interactions in normal and neoplastic prostate. Br J Urol 1997;79(Suppl 2):18-26.
38. Prins G, Birch L, Greene G. Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 1991;129: 3187-99.
39. Prins GS, Birch L. The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology 1995;136:1303-14.
40. Wang Y, Sudilovsky D, Zhang B, Haughney PC, Rosen MA, Wu DS, et al. A human prostatic epithelial model of hormonal carcinogenesis. Cancer Res 2001;61:6064-72.
41. Hayward SW, Dahiya R, Cunha GR, Bartek J, Despande N, Narayan P. Establishment and characterization of an immortalized but nontumorigenic human prostate epithelial cell Line: BPH-1. In Vitro 1995;31A:14-24.
42. Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999;20:358-417.
43. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925-30.
44. Lau KM, Leav I, Ho SM. Rat estrogen receptor-alpha and -beta, and progesterone receptor mRNA expression in various prostatic lobes and microdissected normal and dysplastic epithelial tissues of the Noble rats. Endocrinology 1998;139:424-7.
45. Adams JY, Leav I, Lau KM, Ho SM, Pflueger SM. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate. Prostate 2002;52:69-81.
46. Bosman FT, de Bruine A, Flohil C, van der Wurff A, ten Kate J, Dinjens WW. Epithelial-stromal interactions in colon cancer. Int J Dev Biol 1993;37:203-11.
47. Seljelid R, Jozefowski S, Sveinbjornsson B. Tumor stroma. Anticancer Res 1999;19:4809-22.
48. Dawe CJ. Epithelial-mesenchymal interactions in relation to the genesis of polyoma virus-induced tumours of mouse salivary gland. In: Tarin D, ed. Tissue interactions in carcinogenesis. London: Academic Press, 1972. 305-58.
49. Tarin D. Tissue interactions in xarcinogenesis. London: Academic Press, 1972.
50. De Cosse J, Gossens CL, Kuzma JF. Breast cancer: induction of differentiation by embryonic tissue. Science 1973;181:1057-8.
51. De Cosse JJ, Gossens CL, Kuzma JF, Unsworth BR. Embryonic inductive tissues that cause histological differentiation of murine mammary carcinoma in vitro. J Natl Cancer Inst 1975;54:913-21.
52. Cooper M, Pinkus H. Intrauterine transplantation of rat basal cell carcinoma: a model for reconversion of malignant to benign growth. Cancer Res 1977;37:2544-52.
53. Fujii H, Cunha GR, Norman JT. The induction of adenocarcinomatous differentiation in neoplastic bladder epithelium by an embryonic prostatic inductor. J Urol 1982;128:858-61.
54. Fukamachi H, Mizuno T, Kim YS. Morphogenesis of human colon cancer cells with fetal rat mesenchymes in organ culture. Experientia 1986;42:312-5.
55. Fukamachi H, Mizuno T, Kim YS. Gland formation of human colon cancer cells combined with foetal rat mesenchyme in organ culture: an ultrastructural study. J Cell Sci 1987;87:615-21.
56. Dunning WF. Prostate cancer in the rat. Natl Cancer Inst Monogr 1963;12:351-70.
57. Wong YC, Cunha GR, Hayashi N. Effects of mesenchyme of embryonic urogenital sinus and neonatal seminal vesicle on the cytodifferentiation of the Dunning tumor: ultrastructural study. Acta Anat 1992;143:13950.
58. Cunha GR. Epithelio-mesenchymal interactions in primordial gland structures which become responsive to androgenic stimulation. Anat Rec 1972;172:179-96.
59. Hayashi N, Cunha GR, Wong YC. Influence of male genital tract mesenchymes on differentiation of Dunning prostatic adenocarcinoma. Cancer Res 1990;50:4747-54.
60. Hayashi N, Cunha GR. Mesenchyme-induced changes in neoplastic characteristics of the Dunning prostatic adenocarcinoma. Cancer Res 1991;51:4924-30.
61. Tam NNC, Phil M, Wang YZ, Wong YC. The influence of mesenchyme of neonatal seminal vesicle and embryonic urogenital sinus on the morphologic and functional cytodifferentiation of Dunning prostatic adenocarcinoma: roles of growth factors and proto-oncogenes. Urol Oncol 1997;3:85-93.
62. Hayashi N, Tsuji M, Sugimura Y, Kawamura J, Cunha GR. Change in the morphological and functional cytodifferentiation induced by seminal vesicle mesenchyme in cell suspensions of rat Dunning prostatic adenocarcinoma cells. Int J Cancer 1996;68:788-94.
63. Hayward SW, Cunha GR. The prostate: development and physiology. Radiol Clin North Am 2000;38:1-14.
64. Arnold JT, Isaacs JT. Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault. Endocr Relat Cancer 2002;9:61-73.
65. Rowley DR. What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev 1998;17:411-9.
66. Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer progression. J Urol 2001;166:2472-83.
67. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999;59:5002-11.
68. Hayward SW, Grossfeld GD, Tlsty TD, Cunha GR. Genetic and epigenetic influences in prostatic carcinogenesis. Int J Oncol 1998; 13:35-47.
69. Grossfeld G, Hayward S, Tlsty T, Cunha G. The role of stroma in prostatic carcinogenesis. Endocr Related Cancer 1998;5:253-70.
70. Thompson TC, Timme TL, Kadmon D, Park SH, Egawa S, Yoshida K. Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate. Mol Carcinogenesis 1993;7:165-79.
71. Hayward S, Wang Y, Cao M, Hom Y, Zhang B, Grossfeld G, et al. Malignant transformation in a non-tumorigenic human prostatic epithelial cell line. Cancer Res 2001;61:8135-42.
72. Phillips J, Hayward S, Wang Y, Vasselli J, Pavlovich C, Padilla-Nash H, et al. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res 2001;61:8143-9.
73. Pathak S, Nemeth MA, Multani AS, Thalmann GN, von Eschenbach AC, Chung LW. Can cancer cells transform normal host cells into malignant cells? Br J Cancer 1997;76:1134-8.
74. Basset P, Wolf C, Chambon P. Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review. Breast Cancer Res Treat 1993;24:185-93.
75. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986;47:131-9.
76. Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT, Cullen KJ. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Cancer Res 1995;55:2448-54.
77. Wright JH, McDonnell S, Portella G, Bowden GT, Balmain A, Matrisian LM. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol Carcinog 1994;10:207-15.
78. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, et al. Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol 1989;3:509-17.
79. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996;76:69-125.
80. Schor SL, Schor AM, Rushton G. Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics. J Cell Sci 1988;90:401-7.
81. Chaudhuri S, Koprowska I, Rowinski J. Different agglutinability of fibroblasts underlying various precursor lesions of human uterine cervical carcinoma. Cancer Res 1975;35:2350-4.
82. Oishi K, Romijn JC, Schroeder FH. The surface character of separated prostatic cells and cultured fibroblasts of prostatic tissue as determined by concanavalin-a hemadsorption. Prostate 1981;2:11-21.
83. Ellis MJ, Singer C, Hornby A, Rasmussen A, Cullen KJ. Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer. Breast Cancer Res Treat 1994;31:249-61.
84. Frazier KS, Grotendorst GR. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int J Biochem Cell Biol 1997;29:153-61.
85. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res 1997;57:3305-13.
86. Ponten F, Ren Z, Nister M, Westermark B, Ponten J. Epithelial-stromal interactions in basal cell cancer: the PDGF system. J Invest Dermatol 1994;102:304-9.
87. Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan W. Exon switching and activation of stromal and embryonic FGF/FGF receptor genes in prostate epithelial cells accompanies stromal independence and malignancy. Mol Cell Biol 1993;13:4513-22.
88. Shattuck-Brandt RL, Lamps LW, Heppner-Goss KJ, DuBois RN, Matrisian LM. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms. Mol Carcinog 1999;24: 177-87.
89. -/-) mice. Gastroenterology 2000;118:337-45.
90. Pupa SM, Menard S, Forti S, Tagliabue E. New insights into the role of extracellular matrix during tumor onset and progression. J Cell Physiol 2002;192:259-67.
91. Werb Z, Ashkenas J, MacAuley A, Wiesen JF. Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis. Braz J Med Biol Res 1996;29:1087-97.
92. Wong YC, Tam NNC. Dedifferentiation of stromal smooth muscle as a factor in prostate carcinogenesis. Differentiation 2002;60:633.
93. Arbeit JM, Munger K, Howley PM, Hanahan D. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol 1994;68:4358-68.
94. Coussens LM, Hanahan D, Arbeit JM. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am J Pathol 1996;149:1899-917.
95. van Kempen LCL, Rhee J-S, Dehne K, Lee J, Edwards DR, Coussens LM. Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment. Differentiation 2002;60:610-23.
96. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-44.
97. Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OM. The organizing principal: microenvironmental influences in the normal and malignant breast. Differentiation 2002;60:537-46.
98. Lynch CC, Matrisian LM. MMPs in tumor-host cell communication. Differentiation 2002;60:561-73.
99. Masson R, Lefebvre O, Noel A, Fahime ME, Chenard MP, Wendling C, et al. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol 1998;140:1535-41.
100. Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 1997;94:1402-7.
101. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998;58:1048-51.
102. Itoh T, Tanioka M, Matsuda H, Nishimoto H, Yoshioka T, Suzuki R, et al. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 1999;17:177-81.
103. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-74.
104. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999;98:137-46.
105. Billingham R, Orr J, Woodhouse D. Transplantation of skin components during chemical carcinogenesis with 20-methylcholanthrene. Br J Cancer 1951;5:417-32.
106. Cornil I, Theodorescu D, Man S, Herlyn M, Jambrosic J, Kerbel RS. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA 1991;88:6028-32.
107. Gabbert H. Mechanisms of tumor invasion: evidence from in vivo observations. Cancer Metastasis Rev 1985;4:293-309.
108. Gregoire M, Lieubeau B. The role of fibroblasts in tumor behavior. Cancer Metastasis Rev 1995;14:33950.
109. Redler P, Lustig ES. Differences in the growth-promoting effect of normal and peritumoral dermis on epidermis in vitro. Dev Biol 1968;17:679-91.
110. Turner MA, Darragh T, Palefsky JM. Epithelial-stromal interactions modulating penetration of matrigel membranes by HPV 16-immortalized keratinocytes. J Invest Dermatol 1997;109:619-25.
111. Brauchle M, Angermeyer K, Hubner G, Werner S. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene 1994; 9:3199-204.
112. Thomson AA. Role of androgens and fibroblast growth factors in prostatic development. Reproduction 2001;121:187-95.
113. McKeehan WL, Kan M, Hou J, Wang F, Adams P, Mansson P-E. Heparin-binding (fibroblast) growth factor/receptor gene expression in the prostate. In: Karr J, Coffey DS, Smith RG, Tindall DJ, eds. Molecular and cell biology of prostate cancer. New York: Plenum Press, 1991. 115-26.
114. McKeehan WL, Wang F, Kan M. The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog Nucl Acid Res Mol Biol 1998;59:135-76.
115. Yan G, Fukabori Y, Nikolaropoulos S, Wang F, McKeehan WL. Heparin-binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin. Mol Endocrinol 1992;6:2123-28.
116. Gao J, Arnold JT, Isaacs JT. Conversion from a paracrine to an autocrine mechanism of androgen- stimulated growth during malignant transformation of prostatic epithelial cells. Cancer Res 2001;61: 5038-44.
117. McGarvey TW, Stearns ME. Keratinocyte growth factor and receptor mRNA expression in benign and malignant human prostate. Exp Mol Pathol 1995;63:52-62.
118. Foster BA, Evangelou A, Gingrich JR, Kaplan PJ, DeMayo F, Greenberg NM. Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2iiib promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice. Differentiation 2002;60:624-32.
119. Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res 1997;57:3325-30.
120. Krtolica A, Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol 2002;34:1401-14.